Since transforming growth factor beta (TGF‐β) can act on CAFs to induce collagen production, one group showed that by administration of the TGF‐β inhibitor, SB431542, CAR‐T cell migration and cytotoxicity are restored against ovarian cancer cells.85 The gene discussed is TGFB1; the disease is ovarian cancer.